Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 3
1989 2
1990 2
1991 4
1992 2
1993 3
1994 1
1995 1
1996 1
1997 1
1998 8
1999 3
2000 10
2001 5
2002 3
2003 11
2004 13
2005 9
2006 20
2007 12
2008 12
2009 23
2010 20
2011 10
2012 18
2013 12
2014 11
2015 12
2016 13
2017 14
2018 14
2019 24
2020 25
2021 35
2022 26
2023 4
Text availability
Article attribute
Article type
Publication date

Search Results

340 results
Results by year
Filters applied: . Clear all
Page 1
Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis.
Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, Nunez CM, Patel SR, Penzel T, Pépin JL, Peppard PE, Sinha S, Tufik S, Valentine K, Malhotra A. Benjafield AV, et al. Among authors: ip msm. Lancet Respir Med. 2019 Aug;7(8):687-698. doi: 10.1016/S2213-2600(19)30198-5. Epub 2019 Jul 9. Lancet Respir Med. 2019. PMID: 31300334 Free PMC article. Review.
Non-neovascular age-related macular degeneration with subretinal fluid.
Hilely A, Au A, Freund KB, Loewenstein A, Souied EH, Zur D, Sacconi R, Borrelli E, Peiretti E, Iovino C, Sugiura Y, Ellabban AA, Monés J, Waheed NK, Ozdek S, Yalinbas D, Thiele S, de Moura Mendonça LS, Lee MY, Lee WK, Turcotte P, Capuano V, Filali Ansary M, Chakravarthy U, Lommatzsch A, Gunnemann F, Pauleikhoff D, Ip MS, Querques G, Holz FG, Spaide RF, Sadda S, Sarraf D. Hilely A, et al. Among authors: ip ms. Br J Ophthalmol. 2021 Oct;105(10):1415-1420. doi: 10.1136/bjophthalmol-2020-317326. Epub 2020 Sep 12. Br J Ophthalmol. 2021. PMID: 32920528
Short- and potential long-term adverse health outcomes of COVID-19: a rapid review.
Leung TYM, Chan AYL, Chan EW, Chan VKY, Chui CSL, Cowling BJ, Gao L, Ge MQ, Hung IFN, Ip MSM, Ip P, Lau KK, Lau CS, Lau LKW, Leung WK, Li X, Luo H, Man KKC, Ng VWS, Siu CW, Wan EYF, Wing YK, Wong CSM, Wong KHT, Wong ICK. Leung TYM, et al. Among authors: ip msm. Emerg Microbes Infect. 2020 Dec;9(1):2190-2199. doi: 10.1080/22221751.2020.1825914. Emerg Microbes Infect. 2020. PMID: 32940572 Free PMC article.
Contemporary Concise Review 2020: Sleep.
Ainge-Allen HW, Yee BJ, Ip MSM. Ainge-Allen HW, et al. Among authors: ip msm. Respirology. 2021 Jul;26(7):700-706. doi: 10.1111/resp.14084. Epub 2021 May 20. Respirology. 2021. PMID: 34018277 Free article. Review.
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial.
Aref AA, Scott IU, VanVeldhuisen PC, King J, Ip MS, Blodi BA, Oden NL; Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Investigator Group. Aref AA, et al. Among authors: ip ms. JAMA Ophthalmol. 2021 Dec 1;139(12):1285-1291. doi: 10.1001/jamaophthalmol.2021.4395. JAMA Ophthalmol. 2021. PMID: 34709363 Free PMC article. Clinical Trial.
Reply.
Eadie JA, Ip MS. Eadie JA, et al. Among authors: ip ms. Retina. 2016 Feb;36(2):e10-2. doi: 10.1097/IAE.0000000000000918. Retina. 2016. PMID: 26696314 No abstract available.
Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18.
Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA; SCORE2 Study Investigator Group. Scott IU, et al. Among authors: ip ms. JAMA Ophthalmol. 2022 May 1;140(5):458-464. doi: 10.1001/jamaophthalmol.2022.0352. JAMA Ophthalmol. 2022. PMID: 35323843 Clinical Trial.
340 results